MedTrace Logo

Clinical Validation of Radiomics Artificial Intelligence: Application to Breast Cancer Treatment Planning

NCT05070884 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2023-02-03

No results posted yet for this study

Summary

RadioVal will develop and implement interoperable solutions for clinical deployment of the radiomics tools, including information, training, and communication packages for clinicians and patients, as well as standard operating procedures for the integration of radiomics in clinical oncology. With this study, we will clinically validate these solutions, by looking at their reliability for precise breast cancer diagnosis, treatment recommendation and prognosis estimate, treatment response, evaluation of residual disease and outcome prediction.

Conditions

Interventions

OTHER

The development of new clinical AI solutions to predict treatment response to neoadjuvant chemotherapy (NAC) in breast cancer

Evaluate response to neoadjuvant treatment in advanced breast cancer

Sponsors & Collaborators

  • Karolinska Institutet

    collaborator OTHER

  • Medical University of Gdansk

    collaborator OTHER

  • Medical School University of Zagreb

    collaborator UNKNOWN

  • Medical University of Vienna

    collaborator OTHER

  • Hacettepe University Hospital

    collaborator UNKNOWN

  • Alexander Fleming Institute

    collaborator UNKNOWN

  • Ain Shams University

    collaborator OTHER

  • Instituto de Investigacion Sanitaria La Fe

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2025-08-31
Completion
2025-12-31

Countries

  • Argentina
  • Austria
  • Croatia
  • Egypt
  • Poland
  • Spain
  • Sweden
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05070884 on ClinicalTrials.gov